A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
Public ClinicalTrials.gov record NCT07664553. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin (Eluminate-3)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with placebo in adults with Type 2 Diabetes Mellitus (T2DM), treated with a background insulin and other background glucose-lowering medication(s)
Study identification
- NCT ID
- NCT07664553
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 600 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 8, 2026 (Actual)
- Primary completion
- May 23, 2028 (Estimated)
- Completion
- May 23, 2028 (Estimated)
- Last update posted
- Aug 4, 2026
2026 – 2028
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Little Rock | Arkansas | 72205 | Not yet recruiting |
| Research Site | Sacramento | California | 95821 | Not yet recruiting |
| Research Site | Aurora | Colorado | 80045 | Not yet recruiting |
| Research Site | DeLand | Florida | 32720 | Suspended |
| Research Site | Doral | Florida | 33166 | Not yet recruiting |
| Research Site | Ocoee | Florida | 34761 | Recruiting |
| Research Site | Decatur | Georgia | 30030 | Not yet recruiting |
| Research Site | Potomac | Maryland | 20854 | Not yet recruiting |
| Research Site | Brooklyn | New York | 11220 | Suspended |
| Research Site | Cary | North Carolina | 27518 | Not yet recruiting |
| Research Site | Morehead City | North Carolina | 28557 | Not yet recruiting |
| Research Site | Myrtle Beach | South Carolina | 29572 | Not yet recruiting |
| Research Site | Memphis | Tennessee | 38119 | Not yet recruiting |
| Research Site | Houston | Texas | 77040 | Not yet recruiting |
| Research Site | Round Rock | Texas | 78681 | Not yet recruiting |
| Research Site | San Antonio | Texas | 78231 | Not yet recruiting |
| Research Site | Renton | Washington | 98057 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 115 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07664553, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 4, 2026 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07664553 live on ClinicalTrials.gov.